Phase II study of NK012 in relapsed small cell lung cancer von Raefsky, E., Spigel, D. R., Infante, J. R., Bendell, J. C., Jones, S. F., Lipman, A. J., Trent, D., Kawamura, S., Greco, F. A., Hainsworth, J. D., Burris, H. A.

Volltext

Tracheoesophageal (TE) fistula development in a phase II trial of concurrent chemoradiation (CRT) and bevacizumab (B) in limited-stage small-cell lung cancer (LS-SCLC) von Spigel, D. R., Hainsworth, J. D., Farley, C., Meng, C., Blake, D., Burris, H. A., Raefsky, E., Patton, J., Hart, L. L., Greco, F. A.

Volltext

Studies of interferon as a regulator of hematopoietic cell proliferation von Raefsky, EL, Platanias, LC, Zoumbos, NC, Young, NS

Volltext

Safety data from a phase II study of neoadjuvant bevacizumab and trastuzumab administered with albumin bound paclitaxel (nab paclitaxel) and carboplatin in HER2+ locally advanced b... von Yardlev, D, Raefsky, E, Castillo, R, Lahiry, A, Thompson, D, Hanson, S, Meng, C, Knauer, D, Trieu, V, Desai, N

Volltext

Abstract P4-16-04: Amrubicin as second- or third-line treatment for patients with HER2-negative metastatic breast cancer (MBC): Final results from a phase II trial of the Sarah Can... von Yardley, DA, Barton, J, Raefsky, E, Harwin, W, Priego, V, Inclan, A, Miletello, G, Hart, LL, Shastry, M, Finney, L, Hainsworth, JD, Burris, HA

Volltext

Biological and Immunological Characterization of ATG and ALG von Raefsky, Eric L., Gascon, Pedro, Gratwohl, Alois, Speck, Bruno, Young, Neal S.

Volltext

Amrubicin as second- or third-line treatment for patients with HER2-negative metastatic breast cancer (MBC): A Sarah Cannon Research Institute phase I trial von Barton, J. H., Shih, K. C., Raefsky, E., Haines, D. W., Strike, B., Hainsworth, J. D., Burris, H. A., Yardley, D. A.

Volltext

A phase I trial of protracted oral fixed‐dose temozolomide von Jones, Suzanne F., Greco, F. Anthony, Gian, Victor G., Miranda, Fernando T., Raefsky, Eric L., Hainsworth, John D., Willcutt, Noel T., Beschorner, Aurelia F., Kennerly, Glyndon, Burris, Howard A.

Volltext

Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell Lung carcinoma: A feasibility study of the Minnie Pearl Cancer Research Network von GRECO, F. Anthony, BURRIS, Howard A, HAINSWORTH, John D, GRAY, James R, RAEFSKY, Eric L, DOBBS, Charles, SMITH, Steven, RINALDI, David, MORRISSEY, Lisa H, ERLAND, Joan B, LITCHY, Sharlene

Volltext

P3-14-29: Neoadjuvant Sunitinib Administered with Weekly Paclitaxel/Carboplatin in Patients with Locally Advanced Triple-Negative Breast Cancer: A Sarah Cannon Research Institute P... von Yardley, DA, Peacock, NW, Peyton, J, Shipley, DL, Spigel, S, Barton, J, Shih, KC, Raefsky, E, Liggett, W, Burris, HA, Hainsworth, JD

Volltext

Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer : outcomes by intent to tr... von WEAVER, C. H, WEST, W. H, RAEFSKY, E, KALMAN, L, BUCKNER, C. D, SCHWARTZBERG, L. S, ALBERICO, T, LEFF, R, GRECO, F. A, HAINSWORTH, J, BIRCH, R, MCANENY, B, MAGEE, M

Volltext

Preliminary safety results from a multicenter phase II trial of nanoparticle albumin-bound paclitaxel/cyclophosphamide in early stage breast cancer plus trastuzumab in HER-2+ patie... von Raefsky, E., Inhorn, R., Lange, M., Peacock, N., Shastry, M., Vazquez, E., Priego, V., Franco, L., Hainsworth, J. D., Yardley, D. A.

Volltext

Results of a multicenter pilot study of weekly nab-paclitaxel, carboplatin with bevacizumab, and trastuzumab as neoadjuvant therapy in HER2+ locally advanced breast cancer with SPA... von Yardley, D. A., Raefsky, E., Castillo, R., Lahiry, A., LoCicero, R., Thompson, D., Shastry, M., Trieu, V., Knauer, D., Desai, N.

Volltext

Preliminary safety results from a multicenter phase II noncomparative two arm pilot of bevacizumab with anastrozole or fulvestrant as 1st line metastatic breast cancer therapy von Yardley, DA, Peacock, N, Arrowsmith, E, Harwin, W, Miletello, G, Raefsky, E, Shipley, D, Spigel, DR, Hanson, S, Greco, F

Volltext

First-line treatment with single agent rituximab, followed by maintenance rituximab plus anti-idiotype Id-KLH active immunotherapy vaccine (FavId) in patients (pts) with low-grade... von Raefsky, E., Greco, F. A., Spigel, D. R., Litchy, S., Gian, V., Bender, J., Hainsworth, J. D.

Volltext

A phase I study evaluating a novel schedule of oral eniluracil (EU) combined with escalating doses of oral 5-fluorouracil (5- FU) von Murphy, P. B., Raefsky, E., Burris, H. A., Infante, J. R., Jones, S. F., Spigel, D. R., Dickson, N., Lawton, M., Dicksey, J. S., Peters, W. P.

Volltext

Phase II trial of satraplatin (S) and paclitaxel (P) in first-line advanced non-small cell lung cancer (NSCLC) treatment: Final results von Thompson, D. S., Spigel, D. R., Hainsworth, J. D., Jones, S. F., Burris, H. A., Sade, L., Raefsky, E., Greco, F. A., Yun, S., Noursalehi, M.

Volltext

Phase II study of neoadjuvant bevacizumab and trastuzumab administered with albumin-bound paclitaxel (nab paclitaxel) and carboplatin in HER2+ locally advanced breast cancer von Raefsky, E., Castillo, R., Lahiry, A., Thompson, D. S., Hanson, S., Meng, C., Knauer, D., Trieu, V., Desai, N., Yardley, D. A.

Volltext

Biweekly neoadjuvant gemcitabine, epirubicin, and nano-particle albumin bound (nab) paclitaxel (GEA) with tumor SPARC analysis correlated with pathologic responses: Results of a mu... von Daniel, B. R., Doss, H., Gian, V., Meluch, A. A., Murphy, P. B., Peacock, N. W., Raefsky, E., Yardley, D. A., Simons, L., Inhorn, R. C.

Volltext

Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site : A minnie pearl cancer research network phase II... von HAINSWORTH, John D, SPIGEL, David R, RAEFSKY, Eric L, KUZUR, Michel E, YOST, Kathleen, KOMMOR, Michael, LITCHY, Sharlene, GRECO, F. Anthony

Volltext